Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details)

v3.21.2
NON CONTROLLING INTEREST (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Net loss attributable to the non-controlling interest     $ (1,866) $ (32,179)
BioCorRx Pharmaceuticals, Inc [Member]        
Net loss $ (1,643) $ (72,360) $ (7,709) $ (132,971)
Average Non-controlling interest percentage of profit/losses 24.2 24.2 24.2 24.2
Net loss attributable to the non-controlling interest $ (398) $ (17,511) $ (1,866) $ (32,179)